Cutter Capital Management, LP Spring Works Therapeutics, Inc. Transaction History
Cutter Capital Management, LP
- $244 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
242Shares Held
67.4MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$290 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$228 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$140 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$133 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$122 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.53B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...